Z85.79 — Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues
Is Z85.79 billable?
Yes — Z85.79 is billable for FY2027. Z85.79 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. Z85.79 may be submitted for encounters from October 1, 2026 through September 30, 2027.
Z85.79 at a glance
| Code | Z85.79 |
|---|---|
| Description | Personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
What Medicare edits apply to Z85.79?
The Medicare Code Editor screens inpatient claims before they are grouped. These edits name Z85.79 directly.
CMS will reject this code as the principal diagnosis on an inpatient claim. It describes something other than the condition chiefly responsible for the admission.
Which MS-DRGs does Z85.79 group to?
Z85.79 sits in MDC 17 and helps define the logic of 3 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 826Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with MCCsurgical
- 827Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures with CCsurgical
- 828Myeloproliferative Disorders or Poorly Differentiated Neoplasms with Major O.R. Procedures without CC/MCCsurgical
How is Z85.79 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to Z85.79. They show the wording a clinician may have documented, which often differs from the Tabular description.
- History › personal › malignant neoplasm › hematopoietic NEC
Excludes1 — never code together
The conditions below can never be reported together with Z85.79 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
Inclusion terms
Alternative wording in documentation that is classified to Z85.79.
Code first — inherited from Z85
The underlying condition below must be sequenced before Z85.79. Z85.79 describes a manifestation and cannot be the principal or first-listed diagnosis.
- any follow-up examination after treatment of malignant neoplasm (Z08)
Use additional code — inherited from Z85
Report an additional code alongside Z85.79 to fully describe the condition. Z85.79 is sequenced first.
Excludes2 — not included here — inherited from Z85
The conditions below are not part of Z85.79, but a patient may have both at the same time. When documentation supports it, Z85.79 and the excluded code may both be reported.
Code also — inherited from Z77-Z99
Two codes may be needed to describe the condition fully. Whether Z85.79 is sequenced first depends on the reason for the encounter.
- any follow-up examination (Z08-Z09)
How long has Z85.79 existed?
Z85.79 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.